This morning, the FDA announced in the Federal Register a request for nominations for members to serve on the Pharmacy Compounding Advisory Committee (Committee), Division of Advisory Committee Consultant Management, Center for Drug Evaluation and Research. The Committee provides advice on scientific, technical, and medical issues concerning human drug compounding under the Federal Food, Drug, and Cosmetic Act (FD&C Act), and, as required, any other product for which FDA has regulatory responsibility, and makes appropriate recommendations to the Commissioner of Food and Drugs. Nominations are due by May 29, 2018.
All nominations for membership should be sent electronically by logging into the FDA Advisory Nomination Portal: https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm or by mail to:
Advisory Committee Oversight and Management Staff, Food and Drug Administration
10903 New Hampshire Ave., Bldg. 32, Rm. 5103
Silver Spring, MD 20993-0002
For additional information, please click here